You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Puma

Showing 1 - 25 of 117
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

PUMA (Paediatric Osseous Marrow Assessment)

Recruiting
  • Leukaemia
    • Sutton, Surrey, United Kingdom
      The Institute of Cancer Research and Royal Marsden NHS Foundatio
    Dec 13, 2022

    Gastrostomy, Gastrostomy Complications, Pediatric Disorder Trial in Washington, New York, Philadelphia (Percutaneous Ultrasound

    Recruiting
    • Gastrostomy
    • +3 more
    • Percutaneous Ultrasound Gastrostomy
    • Washington, District of Columbia
    • +2 more
    Jul 31, 2023

    Risk Reduction Trial in Thika (PUMA)

    Active, not recruiting
    • Risk Reduction
    • PUMA
    • Thika, Near Nairobi, Kenya
      KEMRI Partners in Health and Research Development (PHRD), Thika
    Jan 11, 2023

    Psychological Disorder Trial in Stockholm (PUMA+, PUMA)

    Active, not recruiting
    • Psychological Disorder
    • PUMA+
    • PUMA
    • Stockholm, Sweden
      Uppsala University
    Aug 19, 2022

    Colorectal Cancer Trial (Pembrolizumab)

    Recruiting
    • Colorectal Cancer
    • Amsterdam, Netherlands
      Netherlands Cancer Institute
    Jan 3, 2023

    GastroEsophageal Cancer, Gastric Cancer Trial in Tampa (Neratinib, Trastuzumab, Oxaliplatin)

    Recruiting
    • GastroEsophageal Cancer
    • Gastric Cancer
    • Tampa, Florida
      Moffitt Cancer Center
    Oct 25, 2023

    Spinal Muscular Atrophy Type I, Spinal Muscular Atrophy Type II Trial in Columbus (In-home body weight support harness system)

    Active, not recruiting
    • Spinal Muscular Atrophy Type I
    • Spinal Muscular Atrophy Type II
    • In-home body weight support harness system
    • Columbus, Ohio
      Nationwide Children's Hospital
    Jan 27, 2023

    Gastric Cancer Trial in Philadelphia (Neratinib Pill, Fam-Trastuzumab Deruxtecan-Nxki (TDxD))

    Suspended
    • Gastric Cancer
    • Neratinib Pill
    • Fam-Trastuzumab Deruxtecan-Nxki (TDxD)
    • Philadelphia, Pennsylvania
      Fox Chase Cancer Center
    Jul 6, 2022

    Anatomic Stage I Breast Cancer, Anatomic Stage II Breast Cancer, Anatomic Stage III Breast Cancer Trial in United States

    Not yet recruiting
    • Anatomic Stage I Breast Cancer
    • +3 more
    • Endocrine Therapy
    • +7 more
    • Atlanta, Georgia
    • +4 more
    Jun 15, 2023

    Psychological Disorder Trial in Stockholm (Puma)

    Recruiting
    • Psychological Disorder
    • Puma
    • Stockholm, Sweden
      Uppsala University
    Mar 21, 2022

    Metastatic Prostate Adenocarcinoma, Castration-resistant Prostate Cancer, Prostate Cancer Trial in Boston (Neratinib)

    Terminated
    • Metastatic Prostate Adenocarcinoma
    • +3 more
    • Boston, Massachusetts
    • +2 more
    Jul 18, 2022

    Solid Tumor, Adult Trial in Richmond (Neratinib, Divalproex Sodium)

    Recruiting
    • Solid Tumor, Adult
    • Richmond, Virginia
      Virginia Commonwealth University Massey Cancer Center
    Mar 2, 2022

    Advanced Solid Tumor, Ovarian Cancer Trial in Richmond (Neratinib 160 mg, Neratinib 200 mg, Neratinib 240 mg)

    Recruiting
    • Advanced Solid Tumor
    • Ovarian Cancer
    • Neratinib 160 mg
    • +7 more
    • Richmond, Virginia
      Virginia Commonwealth University
    May 6, 2022

    Breast Cancer Trial in United States (Neratinib, Fulvestrant)

    Active, not recruiting
    • Breast Cancer
    • Indianapolis, Indiana
    • +5 more
    Mar 2, 2022

    Breast Cancer, HER2-positive Breast Cancer, ER Positive Breast Cancer Trial (Neratinib, Letrozole (L) or Anastrozole (A),

    Not yet recruiting
    • Breast Cancer
    • +3 more
    • (no location specified)
    Jan 11, 2022

    Early-stage Breast Cancer, HER2 Positive Breast Cancer, Hormone Receptor Positive Trial (Neratinib, Loperamide, Colesevelam)

    Not yet recruiting
    • Early-stage Breast Cancer
    • +2 more
    • (no location specified)
    Aug 5, 2022

    HER2-positive Breast Cancer, Breast Adenocarcinoma, Stage II Breast Cancer AJCC v6 and v7 Trial in San Francisco (Neratinib,

    Completed
    • HER2-positive Breast Cancer
    • +8 more
    • San Francisco, California
      University of California, San Francisco
    Jan 6, 2023

    Metastatic Breast Cancer, Breast Cancer Trial in Houston (Neratinib, Capmatinib)

    Not yet recruiting
    • Metastatic Breast Cancer
    • Breast Cancer
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 16, 2022

    Stage IV (Metastatic) Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer Trial in Boston (NERATINIB,

    Not yet recruiting
    • Stage IV (Metastatic) Breast Cancer
    • +5 more
    • Boston, Massachusetts
      Massachusetts General Hospital
    Oct 25, 2021

    Glioblastoma Trial in United States (Temozolomide, Neratinib, QBS10072S)

    Active, not recruiting
    • Glioblastoma
    • Birmingham, Alabama
    • +11 more
    Aug 15, 2022

    Breast Cancer Trial in United States (Capecitabine, Neratinib, EORTC QLQ - BR23, EQ-5D-5L, EORTC QLQ-C30)

    Active, not recruiting
    • Breast Cancer
    • Hartford, Connecticut
    • +9 more
    Apr 15, 2022

    Hematologic Malignancies Trial in United States (ProHema-CB, Untreated CB)

    Terminated
    • Hematologic Malignancies
    • ProHema-CB
    • Untreated CB
    • Duarte, California
    • +10 more
    Nov 26, 2021

    Breast Cancer Trial in United States (HKI-272, Surgical Resection, Capecitabine)

    Active, not recruiting
    • Breast Cancer
    • San Francisco, California
    • +17 more
    Jan 30, 2023

    Jejunostomy; Complications, Enteral and Supplement Feeds Adverse Reaction, Safety Issues Trial in Baltimore (Percutaneous

    Not yet recruiting
    • Jejunostomy; Complications
    • +2 more
    • Percutaneous Ultrasound Jejunostomy
    • Baltimore, Maryland
      University of Maryland Medical Center
    Oct 18, 2023

    Small Cell Lung Cancer Trial in Cleveland (Alisertib)

    Not yet recruiting
    • Small Cell Lung Cancer
    • Cleveland, Ohio
      Cleveland Clinic
    Oct 18, 2023